PATENT CLAIM ANALYSIS

Application Number: 15575903
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "230800"]

Abstract:
The present invention discloses a pyrido-azacyclic compound represented by formula I, an isomer thereof, a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate thereof, a preparation process thereof and a composition comprising the compound, and a use thereof as a multi-target protein kinase inhibitor in the preparation of a medicament for the treatment of diseases that are associated with protein kinase, especially c-Met, such as cancer and the like. The compound represented by formula I has potent inhibitory activity on tumor cells with overexpression of c-Met kinase, can effectively target c-Met-mediated signaling pathway, and can be used in the treatment of diseases such as cancer and the like that is caused by the overexpression of c-Met kinase.

Claim (Index 9):
The use according to  claim 8 , wherein, the tumor is lung cancer, medullary thyroid tumor, glioblastoma, stomach cancer, renal cell cancer, breast cancer, ovarian cancer, prostate cancer or colorectal cancer.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 1.92424
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14916177', '14763468', '13509442', '13801753', '14383803']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.756358165890984
- 35 USC 102 Novelty (BERT): 0.5446999302395287
- Combined Prediction Score: 0.7351923423258385
- Mean Citation Score: 360.248268
- Max Citation Score: 382.27582
- Similarity Product: 213.9316639190125

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test